CVLB - Conversion Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Conversion Labs, Inc.

800 Third Avenue
Suite 2800
New York, NY 10022
United States

IndustryPharmaceutical Retailers
Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Mr. Justin SchreiberChairman, Pres & CEON/AN/A1983
Mr. Stefan GalluppiCOO, Chief Technology Officer & Director72kN/A1987
Dr. Joseph V. DiTrolioChief Medical Officer of North America & DirectorN/AN/A1951
Mr. Robert KalksteinAdvisor to the CEO90kN/A1982
Mr. Sean FitzpatrickChief Acquisition Officer101.75kN/A1983
Amounts are as of December 31, 2018 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; PDF Simpli, a PDF conversion software; and Scarology, a three step scar care system designed to enhance the color, texture, and appearance of scars. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.

Corporate Governance

Conversion Labs, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.